Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age

Award Number: K99AG086524
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 12/01/2024
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age - PROJECT SUMMARY/ABSTRACT Skeletal muscle atrophy and dysfunction are a hallmark of aging, sarcopenia, and disuse atrophy that significantly affect individual health span and quality of life. There are currently no effective treatments for age related muscle dysfunction because underlying mechanisms that contribute to muscle pathology are not fully understood. A recently published manuscript from the PI shows that protein synthesis and mTOR activity, a primary regulator of protein synthesis, is high in aged muscle, likely inhibiting TFEB (transcription factor EB) nuclear translocation and subsequent activity. This finding suggests that impaired protein degradation, not protein synthesis, compromises maintenance and recovery of aged muscle. We also showed that there was an accumulation of insoluble ubiquitinated proteins and p62 protein in the insoluble fraction of old muscle. Together, these data suggest that compromised autophagy dependent protein degradation likely impacts skeletal muscle function in aged muscle with sarcopenia and recovery after disuse atrophy. The goal of this project is to determine if TFEB functions as a critical node in muscle maintenance with sarcopenia and recovery with disuse atrophy in aged muscle. TFEB stimulates lysosomal biogenesis and autophagy, which are essential in targeted protein degradation and therefore proteostatic maintenance. The hypothesis of this proposal is that TFEB functions as a critical node to improve maintenance and recovery of skeletal muscle mass and function with aging in two conditions of muscle dysfunction, sarcopenia and disuse atrophy. The following Specific Aims are proposed to test the hypothesis: Aim 1: Determine if increasing TFEB activity improves maintenance of muscle mass and function in aged mice. Aim 2: Determine if mTOR activity regulates TFEB-dependent preservation of proteostatic maintenance and muscle function. Aim 3: Test whether increasing TFEB activity can improve recovery of muscle after disuse atrophy in aged mice. If results support the hypothesis, TFEB may be a novel therapeutic target to protect against sarcopenia and improve recovery with disuse atrophy in aged skeletal muscle. The principal investigator (PI) of this grant is a postdoctoral fellow under the mentorship of Dr. Benjamin Miller at Oklahoma Medical Research Foundation (OMRF). The PI will learn state-of-the-art genetic, molecular, and physiological techniques in mouse and Drosophila melanogaster (fruit flies) to test the effects of TFEB on skeletal muscle proteostasis, in vivo and ex vivo muscle function, protein turnover with stable isotopes, and large proteomics data set bioinformatics analysis. The PI will learn these novel techniques from the mentoring team consisting of Drs. Benjamin Miller, Holly Van Remmen, Fabio Demontis, and Wan Hee Yoon. The mentoring team will monitor the progress of the PI and will also give advice for starting a new laboratory, recruiting members to the PI’s laboratory, and mentoring future scientists as the PI transitions towards research independence.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $135,057 )
2026	2026	OKLAHOMA MEDICAL RESEARCH FOUNDATION	825 NE 13TH ST	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Aging Research	001	2	2/24/2026	NON-COMPETING CONTINUATION	$0
2026	2026	OKLAHOMA MEDICAL RESEARCH FOUNDATION	825 NE 13TH ST	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Aging Research	000	2	12/10/2025	NON-COMPETING CONTINUATION	$135,057
														Subtotal = $135,057

Issue Date FY: 2025 ( Subtotal = $135,057 )
2025	2025	OKLAHOMA MEDICAL RESEARCH FOUNDATION	825 NE 13TH ST	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Aging Research	000	1	11/22/2024	NEW	$135,057
2025	2025	OKLAHOMA MEDICAL RESEARCH FOUNDATION	825 NE 13TH ST	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Aging Research	002	1	7/9/2025	OTHER REVISION	$0
2025	2025	OKLAHOMA MEDICAL RESEARCH FOUNDATION	825 NE 13TH ST	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Aging Research	001	1	5/29/2025	TERMINATION	$0
														Subtotal = $135,057

Grand Total All Awards = $270,114

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age

Award Number: K99AG086524

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 12/01/2024

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer